News tagged ‘ProstateCancer’ clear
- The vaccine, which contained weakened poxviruses genetically programmed to spur an immune system attack on prostate tumor cells, helped patients lived longer than patients who received a placebo vaccine.
Tags: ProstateCancer, TranslationalResearch
- Men with metastatic, hormone-sensitive prostate cancer gained more than a year of survival when they received both hormone-blocking medications and chemotherapy right after diagnosis, rather than delaying the chemo until the cancer worsened, according to a study led by Dana-Farber’s Christopher Sweeney published in the New England Journal of Medicine.
Tags: chemotherapy, ProstateCancer
- Analysis finds higher quality of life for men diagnosed with low-risk
prostate cancer who choose ongoing exams over immediate treatment.
- Deprived of androgen hormones, the receptor finds an alternative genetic
pathway to continue growth of prostate cancer cells. An understanding
of this behavior could lead to new therapies targeting specific genes.
Tags: BasicResearch, ProstateCancer, Genetics
- Nine-fold higher pancreatic cancer risk suggests people with this genetic syndrome should be closely monitored.
Tags: ProstateCancer, Genetics
- New research suggests that cholesterol-lowering statin drugs could be a valuable addition to current therapies for prostate cancer.
- A new SU2C and Prostate Cancer Foundation Dream Team, dedicated to advanced prostate cancer research, includes two Dana-Farber researchers among scientists from leading prostate cancer centers in the U.S. and England.
- Researchers at Dana-Farber/Brigham and Women's Cancer Center report a small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, causing them to regret the type of treatment they chose.
Tags: ProstateCancer, PopulationScience
- In prostate cancer patients with a certain genetic variant, a high level
of selenium in the blood was associated with a two-fold greater risk of
poorer outcomes than men with the lowest amounts of selenium.
Tags: BasicResearch, ProstateCancer
- Researchers from the Broad Institute, Dana-Farber Cancer Institute and
Weill Cornell Medical College have laid bare the full genetic blueprint
of multiple prostate tumors, uncovering alterations that have never
before been detected and offering a deep view of the genetic missteps
that underlie the disease.
Tags: Genomics, ProstateCancer